The identification of CHK1 as a putative RelA T505 kinase linked these atypical consequences of NF-κB activity to DNA replication stress, a common feature of cancer cells and to activation of oncogenes such as MYC in particular [21]. The gene discussed is MYC; the disease is cancer.